Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Hypertension in adults: diagnosis and management

NICE guideline
Reference number: NG136
Published: 28 August 2019
Last updated: 21 November 2023

History

Surveillance consultation

Surveillance consultation
Consultation questions (PDF 313 KB)

Published:

23 November 2022
Supporting documentation (PDF 645 KB)

Published:

23 November 2022
Surveillance review proposal (PDF version) (PDF 254 KB)

Published:

23 November 2022
Surveillance review proposal (online version)

Stakeholder list updated

Stakeholder list (PDF 56 KB)

Published:

22 November 2022

Guidance published

Consultation comments and responses (PDF 497 KB)

Published:

18 March 2022
Committee member list (PDF 127 KB)

Published:

18 March 2022
Equality impact assessment 4 (PDF 140 KB)

Published:

18 March 2022

Declaration of interests

Register of interests (PDF 516 KB)

Published:

17 March 2022

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 208 KB)

Published:

01 December 2021
Evidence review A (PDF 2.84 MB)

Published:

01 December 2021
Evidence review B (PDF 3.07 MB)

Published:

01 December 2021
Equality impact assessment 3 (PDF 158 KB)

Published:

01 December 2021
Supporting documentation Methods (PDF 672 KB)

Published:

01 December 2021
Committee member list (PDF 128 KB)

Published:

01 December 2021
Supporting documentation Acknowledgements (PDF 174 KB)

Published:

01 December 2021
Comments form (MSWord 40 KB)

Published:

01 December 2021

Pre-consultation documents released

Economic plan (PDF 19 KB)

Published:

27 October 2021
Review questions (PDF 78 KB)

Published:

27 October 2021
Search strategies (PDF 369 KB)

Published:

27 October 2021

Committee meetings

Committee meeting
Minutes 1 (PDF 145 KB)

Published:

01 July 2021
Minutes 2 (PDF 145 KB)

Published:

09 August 2021
Minutes 3 (PDF 125 KB)

Published:

27 September 2021
Minutes 4 (PDF 123 KB)

Published:

13 October 2021
Minutes 5 (PDF 125 KB)

Published:

20 January 2022

Scope published

Final scope (PDF 184 KB)

Published:

26 April 2021
Consultation comments and responses (PDF 617 KB)

Published:

26 April 2021
Equality impact assessment 2 (PDF 119 KB)

Published:

26 April 2021

Draft scope consultation

Draft scope consultation
Equality impact assessment 1 (PDF 164 KB)

Published:

16 February 2021
Comments form (MSWord 37 KB)

Published:

16 February 2021
Draft scope (PDF 204 KB)

Published:

16 February 2021

Original development on 28 August 2019

Guidance published
Consultation comments and responses (PDF 1.86 MB)

Published:

28 August 2019
Equality impact assessment (PDF 209 KB)

Published:

28 August 2019
Committee member list (PDF 120 KB)

Published:

29 August 2019
Draft guidance consultation
Draft guidance consultation
Guideline appendix (PDF 2.39 MB)

Published:

08 March 2019
Evidence review A (PDF 2.26 MB)

Published:

08 March 2019
Evidence review B (PDF 2.08 MB)

Published:

08 March 2019
Evidence review C (PDF 1.77 MB)

Published:

08 March 2019
Evidence review D (PDF 1.43 MB)

Published:

08 March 2019
Evidence review E (PDF 1.4 MB)

Published:

08 March 2019
Evidence review F (PDF 1.26 MB)

Published:

08 March 2019
Evidence review G (PDF 1.2 MB)

Published:

08 March 2019
Evidence review H (PDF 1.06 MB)

Published:

08 March 2019
Evidence review I (PDF 862 KB)

Published:

08 March 2019
Draft guideline (PDF 634 KB)

Published:

08 March 2019
Guideline appendix Acknowledgements (PDF 235 KB)

Published:

08 March 2019
Evidence summary Methods chapter (PDF 1.01 MB)

Published:

08 March 2019
Committee member list Interest register (PDF 763 KB)

Published:

08 March 2019
Committee member list (PDF 120 KB)

Published:

08 March 2019
Comments form (MSWord 37 KB)

Published:

08 March 2019
Comments form (MSWord 37 KB)

Published:

08 March 2019
Guideline appendix Algorithm Diagnosis (PDF 274 KB)

Published:

26 March 2019
Guideline appendix Algorithm Management (PDF 209 KB)

Published:

26 March 2019
Equality impact assessment (PDF 187 KB)

Published:

06 April 2020
Pre-consultation documents released
Economic plan (PDF 156 KB)

Published:

11 January 2019
Review questions (PDF 246 KB)

Published:

11 January 2019
Search strategies 1 (PDF 776 KB)

Published:

11 January 2019
Search strategies 2 (PDF 743 KB)

Published:

11 January 2019
Search strategies 3 (PDF 634 KB)

Published:

11 January 2019
Search strategies 4 (PDF 723 KB)

Published:

11 January 2019
Search strategies 5 (PDF 723 KB)

Published:

11 January 2019
Search strategies 6 (PDF 803 KB)

Published:

11 January 2019
Search strategies 7 (PDF 804 KB)

Published:

11 January 2019
Search strategies 8 (PDF 716 KB)

Published:

11 January 2019
Search strategies 9 (PDF 783 KB)

Published:

11 January 2019
Declaration of interests
Register of interests (PDF 702 KB)

Published:

07 August 2019
Committee list updated
Committee member list (PDF 155 KB)

Published:

08 November 2018
Stakeholder list updated
Stakeholder list (PDF 339 KB)

Published:

26 September 2017
Scope published
Final scope (PDF 274 KB)

Published:

22 September 2017
Consultation comments and responses (PDF 968 KB)

Published:

22 September 2017
Equality impact assessment (PDF 234 KB)

Published:

22 September 2017
Draft scope consultation
Draft scope consultation
Draft scope (PDF 312 KB)

Published:

09 June 2017
Equality impact assessment (PDF 148 KB)

Published:

09 June 2017
Comments form (MSWord 64 KB)

Published:

09 June 2017
Scoping workshop
Workshop notes (PDF 524 KB)

Published:

30 May 2019
Committee meeting
Minutes 1 (PDF 93 KB)

Published:

03 November 2017
Minutes 2 (PDF 178 KB)

Published:

13 December 2017
Minutes 3 (PDF 103 KB)

Published:

01 March 2018
Minutes 24 Jan 2018 (PDF 98 KB)

Published:

20 March 2018
Minutes 28 Feb 2018 (PDF 218 KB)

Published:

30 April 2018
Minutes 25 April 2018 (PDF 199 KB)

Published:

14 June 2018
Minutes 26 April 2018 (PDF 170 KB)

Published:

14 June 2018
Minutes 07 June 2018 (PDF 103 KB)

Published:

17 July 2018
Minutes 11 Jul 2018 (PDF 102 KB)

Published:

10 September 2018
Minutes 5 September 2018 (PDF 142 KB)

Published:

12 October 2018
Minutes 10 Oct 2018 (PDF 91 KB)

Published:

28 November 2018
Minutes 16 Nov 2018 (PDF 159 KB)

Published:

30 May 2019